tradingkey.logo

BRIEF-FDA To Not Take Action Against Compounders For FD&C Act Violations Regarding Semaglutide

ReutersFeb 21, 2025 3:16 PM

- FDA:

  • FDA: CLARIFIES POLICIES FOR COMPOUNDERS AS NATIONAL GLP-1 SUPPLY BEGINS TO STABILIZE

  • FDA: DOES NOT INTEND TO TAKE ACTION AGAINST COMPOUNDERS FOR FD&C ACT VIOLATIONS DEPENDING ON SEMAGLUTIDE INJECTION INCLUSION ON DRUG SHORTAGE LIST

  • FDA: WORKING TO DETERMINE WHETHER DEMAND OR PROJECTED DEMAND FOR DULAGLUTIDE, LIRAGLUTIDE DRUG IN SHORTAGE EXCEEDS AVAILABLE SUPPLY

Further company coverage: [NOVOb.CO]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI